178 related articles for article (PubMed ID: 20716712)
1. Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease.
Carney RM; Freedland KE; Stein PK; Steinmeyer BC; Harris WS; Rubin EH; Krone RJ; Rich MW
Psychosom Med; 2010 Oct; 72(8):748-54. PubMed ID: 20716712
[TBL] [Abstract][Full Text] [Related]
2. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.
Glassman AH; Bigger JT; Gaffney M; Van Zyl LT
Arch Gen Psychiatry; 2007 Sep; 64(9):1025-31. PubMed ID: 17768267
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
[TBL] [Abstract][Full Text] [Related]
4. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction.
McFarlane A; Kamath MV; Fallen EL; Malcolm V; Cherian F; Norman G
Am Heart J; 2001 Oct; 142(4):617-23. PubMed ID: 11579351
[TBL] [Abstract][Full Text] [Related]
5. Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease.
Roest AM; Carney RM; Stein PK; Freedland KE; Meyer H; Steinmeyer BC; de Jonge P; Rubin EH
J Clin Psychiatry; 2012 Jan; 73(1):31-6. PubMed ID: 21903027
[TBL] [Abstract][Full Text] [Related]
6. A case series on the potential effect of omega-3-fatty acid supplementation on 24-h heart rate variability and its circadian variation in children with attention deficit (hyperactivity) disorder.
Buchhorn R; Koenig J; Jarczok MN; Eichholz H; Willaschek C; Thayer JF; Kaess M
Atten Defic Hyperact Disord; 2018 Jun; 10(2):135-139. PubMed ID: 28975530
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Placebo-Controlled Trial of Omega-3 and Sertraline in Depressed Patients With or at Risk for Coronary Heart Disease.
Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
J Clin Psychiatry; 2019 Jun; 80(4):. PubMed ID: 31163106
[TBL] [Abstract][Full Text] [Related]
8. Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study.
Gehi A; Mangano D; Pipkin S; Browner WS; Whooley MA
Arch Gen Psychiatry; 2005 Jun; 62(6):661-6. PubMed ID: 15939843
[TBL] [Abstract][Full Text] [Related]
9. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease.
Carney RM; Freedland KE; Stein PK; Skala JA; Hoffman P; Jaffe AS
Psychosom Med; 2000; 62(5):639-47. PubMed ID: 11020093
[TBL] [Abstract][Full Text] [Related]
10. Low heart rate variability and the effect of depression on post-myocardial infarction mortality.
Carney RM; Blumenthal JA; Freedland KE; Stein PK; Howells WB; Berkman LF; Watkins LL; Czajkowski SM; Hayano J; Domitrovich PP; Jaffe AS
Arch Intern Med; 2005 Jul; 165(13):1486-91. PubMed ID: 16009863
[TBL] [Abstract][Full Text] [Related]
11. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions.
O'Keefe JH; Abuissa H; Sastre A; Steinhaus DM; Harris WS
Am J Cardiol; 2006 Apr; 97(8):1127-30. PubMed ID: 16616012
[TBL] [Abstract][Full Text] [Related]
12. Effect of dietary omega-3 fatty acids on the heart rate and the heart rate variability responses to myocardial ischemia or submaximal exercise.
Billman GE; Harris WS
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2288-99. PubMed ID: 21460198
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression.
Bot M; Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Mann DL
J Psychosom Res; 2011 Jul; 71(1):13-7. PubMed ID: 21665007
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease.
Villa B; Calabresi L; Chiesa G; Risè P; Galli C; Sirtori CR
Pharmacol Res; 2002 Jun; 45(6):475. PubMed ID: 12162948
[TBL] [Abstract][Full Text] [Related]
15. Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective.
Di Minno MN; Tremoli E; Tufano A; Russolillo A; Lupoli R; Di Minno G
Thromb Haemost; 2010 Oct; 104(4):664-80. PubMed ID: 20806105
[TBL] [Abstract][Full Text] [Related]
16. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study.
de Jonge P; Mangano D; Whooley MA
Psychosom Med; 2007 Nov; 69(8):735-9. PubMed ID: 17942844
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-blockade on heart rate variability in patients with coronary artery disease.
Niemelä MJ; Airaksinen KE; Huikuri HV
J Am Coll Cardiol; 1994 May; 23(6):1370-7. PubMed ID: 8176095
[TBL] [Abstract][Full Text] [Related]
18. The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment.
Billman GE
Pharmacol Ther; 2013 Oct; 140(1):53-80. PubMed ID: 23735203
[TBL] [Abstract][Full Text] [Related]
19. Nighttime heart rate and survival in depressed patients post acute myocardial infarction.
Carney RM; Steinmeyer B; Freedland KE; Blumenthal JA; Stein PK; Steinhoff WA; Howells WB; Berkman LF; Watkins LL; Czajkowski SM; Domitrovich PP; Burg MM; Hayano J; Jaffe AS
Psychosom Med; 2008 Sep; 70(7):757-63. PubMed ID: 18725430
[TBL] [Abstract][Full Text] [Related]
20. Depressed mood, positive affect, and heart rate variability in patients with suspected coronary artery disease.
Bhattacharyya MR; Whitehead DL; Rakhit R; Steptoe A
Psychosom Med; 2008 Nov; 70(9):1020-7. PubMed ID: 18941130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
